nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—SLCO1B3—Rifampicin—leprosy	0.271	0.321	CbGbCtD
Cabazitaxel—SLCO1B1—Rifampicin—leprosy	0.158	0.187	CbGbCtD
Cabazitaxel—CYP3A5—Thalidomide—leprosy	0.0717	0.085	CbGbCtD
Cabazitaxel—CYP3A5—Rifampicin—leprosy	0.0695	0.0823	CbGbCtD
Cabazitaxel—CYP2C8—Rifampicin—leprosy	0.0668	0.0791	CbGbCtD
Cabazitaxel—CYP3A5—Dapsone—leprosy	0.0574	0.0679	CbGbCtD
Cabazitaxel—CYP2C8—Dapsone—leprosy	0.0551	0.0653	CbGbCtD
Cabazitaxel—ABCB1—Rifampicin—leprosy	0.0452	0.0536	CbGbCtD
Cabazitaxel—CYP3A4—Rifampicin—leprosy	0.0271	0.0321	CbGbCtD
Cabazitaxel—CYP3A4—Dapsone—leprosy	0.0224	0.0265	CbGbCtD
Cabazitaxel—Disease progression—Thalidomide—leprosy	0.00675	0.0638	CcSEcCtD
Cabazitaxel—Peripheral sensory neuropathy—Thalidomide—leprosy	0.00516	0.0487	CcSEcCtD
Cabazitaxel—TUBB—Menadione—Thalidomide—leprosy	0.00511	1	CbGdCrCtD
Cabazitaxel—Septic shock—Thalidomide—leprosy	0.00488	0.0461	CcSEcCtD
Cabazitaxel—Electrolyte imbalance—Thalidomide—leprosy	0.00353	0.0333	CcSEcCtD
Cabazitaxel—TUBB4B—skin epidermis—leprosy	0.00327	0.0729	CbGeAlD
Cabazitaxel—Febrile neutropenia—Thalidomide—leprosy	0.00245	0.0232	CcSEcCtD
Cabazitaxel—Deep vein thrombosis—Thalidomide—leprosy	0.00242	0.0229	CcSEcCtD
Cabazitaxel—Intestinal obstruction—Thalidomide—leprosy	0.00216	0.0204	CcSEcCtD
Cabazitaxel—TUBB8—testis—leprosy	0.00197	0.0439	CbGeAlD
Cabazitaxel—TUBB8—nervous system—leprosy	0.00193	0.0431	CbGeAlD
Cabazitaxel—TUBA4A—eye—leprosy	0.00186	0.0415	CbGeAlD
Cabazitaxel—Influenza—Dapsone—leprosy	0.00181	0.0171	CcSEcCtD
Cabazitaxel—Cellulitis—Thalidomide—leprosy	0.00162	0.0153	CcSEcCtD
Cabazitaxel—TUBA4A—skin of body—leprosy	0.00162	0.0361	CbGeAlD
Cabazitaxel—Neuropathy peripheral—Dapsone—leprosy	0.00158	0.0149	CcSEcCtD
Cabazitaxel—TUBB4A—eye—leprosy	0.00149	0.0333	CbGeAlD
Cabazitaxel—TUBB2B—eye—leprosy	0.00144	0.0322	CbGeAlD
Cabazitaxel—Colitis—Thalidomide—leprosy	0.00142	0.0134	CcSEcCtD
Cabazitaxel—Candida infection—Thalidomide—leprosy	0.00141	0.0133	CcSEcCtD
Cabazitaxel—TUBB2A—eye—leprosy	0.00136	0.0303	CbGeAlD
Cabazitaxel—Tinnitus—Dapsone—leprosy	0.00135	0.0127	CcSEcCtD
Cabazitaxel—TUBB3—testis—leprosy	0.00134	0.03	CbGeAlD
Cabazitaxel—TUBB3—nervous system—leprosy	0.00132	0.0294	CbGeAlD
Cabazitaxel—TUBB1—testis—leprosy	0.00131	0.0293	CbGeAlD
Cabazitaxel—TUBB4A—skin of body—leprosy	0.0013	0.0289	CbGeAlD
Cabazitaxel—TUBB1—nervous system—leprosy	0.00129	0.0288	CbGeAlD
Cabazitaxel—Sepsis—Thalidomide—leprosy	0.00128	0.0121	CcSEcCtD
Cabazitaxel—Erythema—Dapsone—leprosy	0.00126	0.0119	CcSEcCtD
Cabazitaxel—TUBA4A—tendon—leprosy	0.00123	0.0275	CbGeAlD
Cabazitaxel—TUBB2A—skin of body—leprosy	0.00118	0.0263	CbGeAlD
Cabazitaxel—TUBB6—skin of body—leprosy	0.00116	0.026	CbGeAlD
Cabazitaxel—TUBB4B—eye—leprosy	0.00116	0.026	CbGeAlD
Cabazitaxel—Renal failure acute—Thalidomide—leprosy	0.00116	0.011	CcSEcCtD
Cabazitaxel—Vertigo—Dapsone—leprosy	0.00113	0.0107	CcSEcCtD
Cabazitaxel—Atrial fibrillation—Thalidomide—leprosy	0.00113	0.0107	CcSEcCtD
Cabazitaxel—Cough—Dapsone—leprosy	0.0011	0.0104	CcSEcCtD
Cabazitaxel—Cardiac failure—Thalidomide—leprosy	0.0011	0.0104	CcSEcCtD
Cabazitaxel—Lethargy—Thalidomide—leprosy	0.00109	0.0103	CcSEcCtD
Cabazitaxel—Pain in extremity—Thalidomide—leprosy	0.00107	0.0101	CcSEcCtD
Cabazitaxel—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00107	0.0101	CcSEcCtD
Cabazitaxel—TUBA4A—testis—leprosy	0.00102	0.0228	CbGeAlD
Cabazitaxel—Cardiac arrest—Thalidomide—leprosy	0.00102	0.00961	CcSEcCtD
Cabazitaxel—TUBB4B—skin of body—leprosy	0.00101	0.0226	CbGeAlD
Cabazitaxel—Tachycardia—Dapsone—leprosy	0.001	0.00947	CcSEcCtD
Cabazitaxel—TUBA4A—nervous system—leprosy	0.001	0.0223	CbGeAlD
Cabazitaxel—Dehydration—Thalidomide—leprosy	0.000995	0.0094	CcSEcCtD
Cabazitaxel—TUBB4A—tendon—leprosy	0.000988	0.022	CbGeAlD
Cabazitaxel—Dry skin—Thalidomide—leprosy	0.000981	0.00927	CcSEcCtD
Cabazitaxel—Orthostatic hypotension—Thalidomide—leprosy	0.000977	0.00924	CcSEcCtD
Cabazitaxel—Hypokalaemia—Thalidomide—leprosy	0.000974	0.0092	CcSEcCtD
Cabazitaxel—Breast disorder—Thalidomide—leprosy	0.000967	0.00914	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000963	0.00911	CcSEcCtD
Cabazitaxel—TUBB2B—tendon—leprosy	0.000955	0.0213	CbGeAlD
Cabazitaxel—Alanine aminotransferase increased—Thalidomide—leprosy	0.000944	0.00892	CcSEcCtD
Cabazitaxel—Abdominal distension—Thalidomide—leprosy	0.000931	0.0088	CcSEcCtD
Cabazitaxel—Influenza—Thalidomide—leprosy	0.000925	0.00874	CcSEcCtD
Cabazitaxel—TUBB—tendon—leprosy	0.000904	0.0202	CbGeAlD
Cabazitaxel—TUBB2A—tendon—leprosy	0.000899	0.02	CbGeAlD
Cabazitaxel—TUBB6—tendon—leprosy	0.000887	0.0198	CbGeAlD
Cabazitaxel—Neutropenia—Thalidomide—leprosy	0.000865	0.00817	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Thalidomide—leprosy	0.000859	0.00812	CcSEcCtD
Cabazitaxel—Pollakiuria—Thalidomide—leprosy	0.000854	0.00807	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Dapsone—leprosy	0.00084	0.00794	CcSEcCtD
Cabazitaxel—Weight decreased—Thalidomide—leprosy	0.000837	0.00791	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Thalidomide—leprosy	0.000834	0.00788	CcSEcCtD
Cabazitaxel—Pneumonia—Thalidomide—leprosy	0.000829	0.00784	CcSEcCtD
Cabazitaxel—Infestation—Thalidomide—leprosy	0.000824	0.00779	CcSEcCtD
Cabazitaxel—Infestation NOS—Thalidomide—leprosy	0.000824	0.00779	CcSEcCtD
Cabazitaxel—TUBB4A—testis—leprosy	0.000818	0.0182	CbGeAlD
Cabazitaxel—Body temperature increased—Dapsone—leprosy	0.000812	0.00767	CcSEcCtD
Cabazitaxel—Abdominal pain—Dapsone—leprosy	0.000812	0.00767	CcSEcCtD
Cabazitaxel—Renal failure—Thalidomide—leprosy	0.00081	0.00766	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Thalidomide—leprosy	0.000808	0.00764	CcSEcCtD
Cabazitaxel—TUBB4A—nervous system—leprosy	0.000803	0.0179	CbGeAlD
Cabazitaxel—Conjunctivitis—Thalidomide—leprosy	0.000801	0.00757	CcSEcCtD
Cabazitaxel—TUBB2B—testis—leprosy	0.000791	0.0176	CbGeAlD
Cabazitaxel—Haematuria—Thalidomide—leprosy	0.000786	0.00743	CcSEcCtD
Cabazitaxel—TUBB2B—nervous system—leprosy	0.000776	0.0173	CbGeAlD
Cabazitaxel—TUBB4B—tendon—leprosy	0.000771	0.0172	CbGeAlD
Cabazitaxel—TUBB—testis—leprosy	0.000748	0.0167	CbGeAlD
Cabazitaxel—TUBB2A—testis—leprosy	0.000744	0.0166	CbGeAlD
Cabazitaxel—Hypoaesthesia—Thalidomide—leprosy	0.000736	0.00696	CcSEcCtD
Cabazitaxel—TUBB6—testis—leprosy	0.000734	0.0164	CbGeAlD
Cabazitaxel—Urinary tract disorder—Thalidomide—leprosy	0.000731	0.00691	CcSEcCtD
Cabazitaxel—TUBB2A—nervous system—leprosy	0.000731	0.0163	CbGeAlD
Cabazitaxel—Oedema peripheral—Thalidomide—leprosy	0.000729	0.00689	CcSEcCtD
Cabazitaxel—Urethral disorder—Thalidomide—leprosy	0.000725	0.00686	CcSEcCtD
Cabazitaxel—TUBB6—nervous system—leprosy	0.000721	0.0161	CbGeAlD
Cabazitaxel—Eye disorder—Thalidomide—leprosy	0.000692	0.00654	CcSEcCtD
Cabazitaxel—Tinnitus—Thalidomide—leprosy	0.00069	0.00652	CcSEcCtD
Cabazitaxel—Cardiac disorder—Thalidomide—leprosy	0.000687	0.00649	CcSEcCtD
Cabazitaxel—Angiopathy—Thalidomide—leprosy	0.000671	0.00635	CcSEcCtD
Cabazitaxel—Immune system disorder—Thalidomide—leprosy	0.000668	0.00632	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Thalidomide—leprosy	0.000667	0.0063	CcSEcCtD
Cabazitaxel—Chills—Thalidomide—leprosy	0.000664	0.00628	CcSEcCtD
Cabazitaxel—Arrhythmia—Thalidomide—leprosy	0.000661	0.00625	CcSEcCtD
Cabazitaxel—Alopecia—Thalidomide—leprosy	0.000654	0.00618	CcSEcCtD
Cabazitaxel—Vomiting—Dapsone—leprosy	0.000653	0.00617	CcSEcCtD
Cabazitaxel—Mental disorder—Thalidomide—leprosy	0.000648	0.00613	CcSEcCtD
Cabazitaxel—Malnutrition—Thalidomide—leprosy	0.000644	0.00609	CcSEcCtD
Cabazitaxel—Headache—Dapsone—leprosy	0.000643	0.00608	CcSEcCtD
Cabazitaxel—TUBB4B—testis—leprosy	0.000638	0.0142	CbGeAlD
Cabazitaxel—ABCB1—blood vessel—leprosy	0.000636	0.0142	CbGeAlD
Cabazitaxel—Dysgeusia—Thalidomide—leprosy	0.000631	0.00596	CcSEcCtD
Cabazitaxel—TUBB4B—nervous system—leprosy	0.000626	0.014	CbGeAlD
Cabazitaxel—Back pain—Thalidomide—leprosy	0.000623	0.00589	CcSEcCtD
Cabazitaxel—Muscle spasms—Thalidomide—leprosy	0.000619	0.00585	CcSEcCtD
Cabazitaxel—Nausea—Dapsone—leprosy	0.00061	0.00577	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Thalidomide—leprosy	0.000598	0.00565	CcSEcCtD
Cabazitaxel—Anaemia—Thalidomide—leprosy	0.000595	0.00563	CcSEcCtD
Cabazitaxel—Malaise—Thalidomide—leprosy	0.000581	0.00549	CcSEcCtD
Cabazitaxel—Vertigo—Thalidomide—leprosy	0.000579	0.00547	CcSEcCtD
Cabazitaxel—Leukopenia—Thalidomide—leprosy	0.000577	0.00545	CcSEcCtD
Cabazitaxel—Cough—Thalidomide—leprosy	0.000562	0.00531	CcSEcCtD
Cabazitaxel—Hypertension—Thalidomide—leprosy	0.000556	0.00526	CcSEcCtD
Cabazitaxel—Arthralgia—Thalidomide—leprosy	0.000549	0.00518	CcSEcCtD
Cabazitaxel—Chest pain—Thalidomide—leprosy	0.000549	0.00518	CcSEcCtD
Cabazitaxel—Myalgia—Thalidomide—leprosy	0.000549	0.00518	CcSEcCtD
Cabazitaxel—Anxiety—Thalidomide—leprosy	0.000547	0.00517	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000545	0.00515	CcSEcCtD
Cabazitaxel—Discomfort—Thalidomide—leprosy	0.000542	0.00512	CcSEcCtD
Cabazitaxel—Dry mouth—Thalidomide—leprosy	0.000536	0.00507	CcSEcCtD
Cabazitaxel—Confusional state—Thalidomide—leprosy	0.00053	0.00501	CcSEcCtD
Cabazitaxel—Oedema—Thalidomide—leprosy	0.000526	0.00497	CcSEcCtD
Cabazitaxel—Infection—Thalidomide—leprosy	0.000522	0.00494	CcSEcCtD
Cabazitaxel—Nervous system disorder—Thalidomide—leprosy	0.000516	0.00487	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Thalidomide—leprosy	0.000515	0.00487	CcSEcCtD
Cabazitaxel—Tachycardia—Thalidomide—leprosy	0.000513	0.00485	CcSEcCtD
Cabazitaxel—Skin disorder—Thalidomide—leprosy	0.000511	0.00483	CcSEcCtD
Cabazitaxel—Anorexia—Thalidomide—leprosy	0.000501	0.00474	CcSEcCtD
Cabazitaxel—Hypotension—Thalidomide—leprosy	0.000491	0.00464	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Thalidomide—leprosy	0.000479	0.00453	CcSEcCtD
Cabazitaxel—Paraesthesia—Thalidomide—leprosy	0.000472	0.00446	CcSEcCtD
Cabazitaxel—Dyspnoea—Thalidomide—leprosy	0.000469	0.00443	CcSEcCtD
Cabazitaxel—Dyspepsia—Thalidomide—leprosy	0.000463	0.00437	CcSEcCtD
Cabazitaxel—Decreased appetite—Thalidomide—leprosy	0.000457	0.00432	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Thalidomide—leprosy	0.000454	0.00429	CcSEcCtD
Cabazitaxel—Fatigue—Thalidomide—leprosy	0.000453	0.00428	CcSEcCtD
Cabazitaxel—Pain—Thalidomide—leprosy	0.00045	0.00425	CcSEcCtD
Cabazitaxel—Constipation—Thalidomide—leprosy	0.00045	0.00425	CcSEcCtD
Cabazitaxel—Feeling abnormal—Thalidomide—leprosy	0.000433	0.0041	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Thalidomide—leprosy	0.00043	0.00406	CcSEcCtD
Cabazitaxel—Abdominal pain—Thalidomide—leprosy	0.000416	0.00393	CcSEcCtD
Cabazitaxel—Body temperature increased—Thalidomide—leprosy	0.000416	0.00393	CcSEcCtD
Cabazitaxel—Hypersensitivity—Thalidomide—leprosy	0.000387	0.00366	CcSEcCtD
Cabazitaxel—CYP2C8—testis—leprosy	0.000387	0.00863	CbGeAlD
Cabazitaxel—Asthenia—Thalidomide—leprosy	0.000377	0.00357	CcSEcCtD
Cabazitaxel—ABCG2—testis—leprosy	0.000376	0.00839	CbGeAlD
Cabazitaxel—Diarrhoea—Thalidomide—leprosy	0.00036	0.0034	CcSEcCtD
Cabazitaxel—Dizziness—Thalidomide—leprosy	0.000348	0.00329	CcSEcCtD
Cabazitaxel—Vomiting—Thalidomide—leprosy	0.000334	0.00316	CcSEcCtD
Cabazitaxel—Headache—Thalidomide—leprosy	0.000329	0.00311	CcSEcCtD
Cabazitaxel—Nausea—Thalidomide—leprosy	0.000312	0.00295	CcSEcCtD
Cabazitaxel—CYP3A4—nervous system—leprosy	0.000257	0.00574	CbGeAlD
Cabazitaxel—ABCB1—testis—leprosy	0.000186	0.00414	CbGeAlD
Cabazitaxel—ABCB1—nervous system—leprosy	0.000182	0.00406	CbGeAlD
